SCHEMBL8080972

SCHEMBL8080972

N[C@@H](CC=O)[C@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11402894 0.86 LMNA (0.43)
SCHEMBL11656356 0.86 LMNA (0.43)
SCHEMBL2323889 0.76 USP2 (0.34)
SCHEMBL1198324 0.76
SCHEMBL6272445 0.76 AKR1B1 (0.41)
SCHEMBL37362 0.76
SCHEMBL97624 0.76
SCHEMBL22720618 0.76 AKR1B1 (0.41)
SCHEMBL22720619 0.76 AKR1B1 (0.41)
SCHEMBL574324 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017164615-A1 METHOD FOR PREPARING 3'-AMINO-2',3'-DIDEOXYADENOSINE BY USING NUCLEOSIDE PHOSPHORYLASE DERIVED FROM BACILLUS ST PHARM CO., LTD. (KR) 2017-09-28 WO disclosed
US-6136601-A ADJUSTED NUCLEOTIDE SEQUENCES WHICH CAN BE UTILIZED FOR THE GENERATION OF PREFERENTIAL MUTATION EPOCH PHARMACEUTICALS, INC. (US) 2000-10-24 US disclosed
US-5935830-A SITE-DIRECTED MUTAGENESIS BY FORMING TRIPLE HELIX WITH DOUBLE-STRANDED DNA AND OLIGONUCLEOTIDE WITH ELECTROPHILIC GROUP, ELECTROPHILIC GROUP CAUSES MODIFICATION OF DNA NUCLEOTIDE, THEN REPLICATION CAUSES MUTATION EPOCH PHARMACEUTICALS, INC. (US) 1999-08-10 US disclosed
EP-0021215-B1 PSEUDOTRISACCHARIDES, THEIR PREPARATION AND USE AS MEDICAMENTS BAYER AG (DE) 1983-07-13 EP disclosed
US-4393051-A BACTERICIDES BAYER AKTIENGESELLSCHAFT (DE) 1983-07-12 US disclosed
EP-0021215-A1 Pseudotrisaccharides, their preparation and use as medicaments BAYER AG (DE) 1981-01-07 EP disclosed